Diagnosis and Classification of Pathogens

Genomic and Personalized Medicine

Volumn 2, Issue , 2013, Pages 1096-1105

  Ramilo, Octavio ^a   Mejías, Asunción ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883909885     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-382227-7.00093-8     Document Type: Chapter

References (58)

1. Alizadeh A.A., Eisen M.B., Davis R.E., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511.
2. Ananthakrishnan A.N. Clostridium difficile infection: Epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol 2011, 8:17-26.
3. Anevlavis S., Petroglou N., Tzavaras A., et al. A prospective study of the diagnostic utility of sputum Gram stain in pneumonia. J Infect 2009, 59:83-89.
4. Ardura M.I., Banchereau R., Mejias A., et al. Enhanced monocyte response and decreased central memory T cells in children with invasive Staphylococcus aureus infections. PLoS ONE 2009, 4:e5446.
5. Balada-Llasat J.M., LaRue H., Kelly C., Rigali L., Pancholi P. Evaluation of commercial ResPlex II v2.0, MultiCode-PLx, and xTAG respiratory viral panels for the diagnosis of respiratory viral infections in adults. J Clin Virol 2011, 50:42-45.
6. Bennett L., Palucka A.K., Arce E., et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003, 197:711-723.
7. Berry M.P., Graham C.M., McNab F.W., et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010, 466:973-977.
8. Blumenthal A., Lauber J., Hoffmann R., et al. Common and unique gene expression signatures of human macrophages in response to four strains of Mycobacterium avium that differ in their growth and persistence characteristics. Infect Immun 2005, 73:3330-3341.
9. Boldrick J.C., Alizadeh A.A., Diehn M., et al. Stereotyped and specific gene expression programs in human innate immune responses to bacteria. Proc Natl Acad Sci USA 2002, 99:972-977.
10. Brukman A., Enquist L.W. Suppression of the interferon-mediated innate immune response by pseudorabies virus. J Virol 2006, 80:6345-6356.
11. Bryce J., Boschi-Pinto C., Shibuya K., Black R.E. WHO estimates of the causes of death in children. Lancet 2005, 365:1147-1152.
12. Centres for Disease Control and Prevention, 2009. H1N1 Flu. <>. http://www.cdc.gov/h1n1flu/.
13. Chaussabel D., Allman W., Mejias A., et al. Analysis of significance patterns identifies ubiquitous and disease-specific gene-expression signatures in patient peripheral blood leukocytes. Ann NY Acad Sci 2005, 1062:146-154.
14. Chaussabel D., Pascual V., Banchereau J. Assessing the human immune system through blood transcriptomics. BMC Biol 2010, 8:84.
15. Chaussabel D., Quinn C., Shen J., et al. A modular analysis framework for blood genomics studies: Application to systemic lupus erythematosus. Immunity 2008, 29:150-164.
16. Chaussabel D., Semnani R.T., McDowell M.A., Sacks D., Sher A., Nutman T.B. Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood 2003, 102:672-681.
17. Cortez K.J., Lyman C.A., Kottilil S., et al. Functional genomics of innate host defense molecules in normal human monocytes in response to Aspergillus fumigatus. Infect Immun 2006, 74:2353-2365.
18. Cummings C.A., Relman D.A. Genomics and microbiology. Microbial forensics - "cross-examining pathogens". Science 2002, 296:1976-1979.
19. Fontaine O., Kosek M., Bhatnagar S., et al. Setting research priorities to reduce global mortality from childhood diarrhoea by 2015. PLoS Med 2009, 6:e41.
20. Golub T.R., Slonim D.K., Tamayo P., et al. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 1999, 286:531-537.
21. Griffiths M.J., Shafi M.J., Popper S.J., et al. Genomewide analysis of the host response to malaria in Kenyan children. J Infect Dis 2005, 191:1599-1611.
22. Hall C.B., Weinberg G.A., Iwane M.K., et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009, 360:588-598.
23. Huang Q., Liu D., Majewski P., et al. The plasticity of dendritic cell responses to pathogens and their components. Science 2001, 294:870-875.
24. Jenner R.G., Young R.A. Insights into host responses against pathogens from transcriptional profiling. Nat Rev Microbiol 2005, 3:281-294.
25. Jhaveri R., Kundu P., Shapiro A.M., Venkatesan A., Dasgupta A. Effect of heptitis C virus core protein on cellular gene expression: Specific inhibition of cyclooxygenase 2. J Infect Dis 2005, 191:1498-1506.
26. Johnstone J., Majumdar S.R., Fox J.D., Marrie T.J. Viral infection in adults hospitalized with community-acquired pneumonia: Prevalence, pathogens, and presentation. Chest 2008, 134:1141-1148.
27. Jones J.O., Arvin A.M. Inhibition of the NF-kappaB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo. J Virol 2006, 80:5113-5124.
28. Kim H.S., Choi E.H., Khan J., et al. Expression of genes encoding innate host defense molecules in normal human monocytes in response to Candida albicans. Infect Immun 2005, 73:3714-3724.
29. Klevens R.M., Morrison M.A., Nadle J., et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298:1763-1771.
30. Kunz A.N., Brook I. Emerging resistant gram-negative aerobic bacilli in hospital-acquired infections. Chemotherapy 2010, 56:492-500.
31. Libster R., Bugna J., Coviello S., et al. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med 2010, 362:45-55.
32. Mahony J.B. Detection of respiratory viruses by molecular methods. Clin Microbiol Rev 2008, 21:716-747.
33. Medzhitov R., Janeway C. Innate immune recognition: Mechanisms and pathways. Immunol Rev 2000, 173:89-97.
34. Medzhitov R., Janeway C.A. Innate immunity: The virtues of a nonclonal system of recognition. Cell 1997, 91:295-298.
35. Mossman K.L., Macgregor P.F., Rozmus J.J., Goryachev A.B., Edwards A.M., Smiley J.R. Herpes simplex virus triggers and then disarms a host antiviral response. J Virol 2001, 75:750-758.
36. Mysorekar I.U., Mulvey M.A., Hultgren S.J., Gordon J.I. Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli. J Biol Chem 2002, 277:7412-7419.
37. Nascimento E.J., Braga-Neto U., Calzavara-Silva C.E., et al. Gene expression profiling during early acute febrile stage of dengue infection can predict the disease outcome. PLoS ONE 2009, 4:e7892.
38. Nau G.J., Richmond J.F., Schlesinger A., Jennings E.G., Lander E.S., Young R.A. Human macrophage activation programs induced by bacterial pathogens. Proc Natl Acad Sci USA 2002, 99:1503-1508.
39. Nolte F.S. Molecular diagnostics for detection of bacterial and viral pathogens in community-acquired pneumonia. Clin Infect Dis 2008, 47(Suppl. 3):S123-S126.
40. Pai R.K., Pennini M.E., Tobian A.A., Canaday D.H., Boom W.H., Harding C.V. Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages. Infect Immun 2004, 72:6603-6614.
41. Pankla R., Buddhisa S., Berry M., et al. Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis. Genome Biol 2009, 10:R127.
42. Pascual V., Allantaz F., Patel P., Palucka A.K., Chaussabel D., Banchereau J. How the study of children with rheumatic diseases identified interferon-alpha and interleukin-1 as novel therapeutic targets. Immunol Rev 2008, 223:39-59.
43. Peng T., Kotla S., Bumgarner R.E., Gustin K.E. Human rhinovirus attenuates the type I interferon response by disrupting activation of interferon regulatory factor 3. J Virol 2006, 80:5021-5031.
44. Piqueras B., Connolly J., Freitas H., Palucka A.K., Banchereau J. Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood 2006, 107:2613-2618.
45. Popper S.J., Watson V.E., Shimizu C., Kanegaye J.T., Burns J.C., Relman D.A. Gene transcript abundance profiles distinguish Kawasaki disease from adenovirus infection. J Infect Dis 2009, 200:657-666.
46. Ramilo O., Allman W., Chung W., et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 2007, 109:2066-2077.
47. Ramilo O., Mejias A. Shifting the paradigm: Host gene signatures for diagnosis of infectious diseases. Cell Host Microbe 2009, 6:199-200.
48. Relman D.A. New technologies, human-microbe interactions, and the search for previously unrecognized pathogens. J Infect Dis 2002, 186(Suppl. 2):S254-S258.
49. Relman D.A. The human body as microbial observatory. Nat Genet 2002, 30:131-133.
50. Rudan I., El Arifeen S., Black R.E., Campbell H. Childhood pneumonia and diarrhoea: Setting our priorities right. Lancet Infect Dis 2007, 7:56-61.
51. Schmitz F., Mages J., Heit A., Lang R., Wagner H. Transcriptional activation induced in macrophages by Toll-like receptor (TLR) ligands: From expression profiling to a model of TLR signaling. Eur J Immunol 2004, 34:2863-2873.
52. Thompson L.J., Dunstan S.J., Dolecek C., et al. Transcriptional response in the peripheral blood of patients infected with Salmonella enterica serovar Typhi. Proc Natl Acad Sci USA 2009, 106:22,433-22,438.
53. UNAIDS (Joint United Nations Programme on HIV/AIDS), 2008. Report on the Global AIDS Epidemic. <>. http://www.unaids.org/en/dataanalysis/epidemiology/2008reportontheglobal aidsepidemic/.
54. Wachter R.M., Flanders S.A., Fee C., Pronovost P.J. Public reporting of antibiotic timing in patients with pneumonia: Lessons from a flawed performance measure. Ann Intern Med 2008, 149:29-32.
55. Wang E., Marincola F.M. Bottom up: A modular view of immunology. Immunity 2008, 29:9-11.
56. World Health Organization, 2008. WHO global burden of disease: 2004 update. <>. http://www.who.int/healthinfo/global_burden_disease/2004_report_update/e n/index.html.
57. Zaas A.K., Chen M., Varkey J., et al. Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell Host Microbe 2009, 6:207-217.
58. Zetola N., Francis J.S., Nuermberger E.L., Bishai W.R. Community-acquired methicillin-resistant Staphylococcus aureus: An emerging threat. Lancet Infect Dis 2005, 5:275-286.